Cargando…

Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case–cohort study

AIMS/HYPOTHESIS: Islet autoimmunity may progress to adult-onset diabetes. We investigated whether circulating odd-chain fatty acids (OCFA) 15:0 and 17:0, which are inversely associated with type 2 diabetes, interact with autoantibodies against GAD65 (GAD65Ab) on the incidence of adult-onset diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Lampousi, Anna-Maria, Carlsson, Sofia, Löfvenborg, Josefin E., Cabrera-Castro, Natalia, Chirlaque, María-Dolores, Fagherazzi, Guy, Franks, Paul W., Hampe, Christiane S., Jakszyn, Paula, Koulman, Albert, Kyrø, Cecilie, Moreno-Iribas, Conchi, Nilsson, Peter M., Panico, Salvatore, Papier, Keren, van der Schouw, Yvonne T., Schulze, Matthias B., Weiderpass, Elisabete, Zamora-Ros, Raul, Forouhi, Nita G., Sharp, Stephen J., Rolandsson, Olov, Wareham, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317878/
https://www.ncbi.nlm.nih.gov/pubmed/37301794
http://dx.doi.org/10.1007/s00125-023-05948-x
_version_ 1785067918370799616
author Lampousi, Anna-Maria
Carlsson, Sofia
Löfvenborg, Josefin E.
Cabrera-Castro, Natalia
Chirlaque, María-Dolores
Fagherazzi, Guy
Franks, Paul W.
Hampe, Christiane S.
Jakszyn, Paula
Koulman, Albert
Kyrø, Cecilie
Moreno-Iribas, Conchi
Nilsson, Peter M.
Panico, Salvatore
Papier, Keren
van der Schouw, Yvonne T.
Schulze, Matthias B.
Weiderpass, Elisabete
Zamora-Ros, Raul
Forouhi, Nita G.
Sharp, Stephen J.
Rolandsson, Olov
Wareham, Nicholas J.
author_facet Lampousi, Anna-Maria
Carlsson, Sofia
Löfvenborg, Josefin E.
Cabrera-Castro, Natalia
Chirlaque, María-Dolores
Fagherazzi, Guy
Franks, Paul W.
Hampe, Christiane S.
Jakszyn, Paula
Koulman, Albert
Kyrø, Cecilie
Moreno-Iribas, Conchi
Nilsson, Peter M.
Panico, Salvatore
Papier, Keren
van der Schouw, Yvonne T.
Schulze, Matthias B.
Weiderpass, Elisabete
Zamora-Ros, Raul
Forouhi, Nita G.
Sharp, Stephen J.
Rolandsson, Olov
Wareham, Nicholas J.
author_sort Lampousi, Anna-Maria
collection PubMed
description AIMS/HYPOTHESIS: Islet autoimmunity may progress to adult-onset diabetes. We investigated whether circulating odd-chain fatty acids (OCFA) 15:0 and 17:0, which are inversely associated with type 2 diabetes, interact with autoantibodies against GAD65 (GAD65Ab) on the incidence of adult-onset diabetes. METHODS: We used the European EPIC-InterAct case–cohort study including 11,124 incident adult-onset diabetes cases and a subcohort of 14,866 randomly selected individuals. Adjusted Prentice-weighted Cox regression estimated HRs and 95% CIs of diabetes in relation to 1 SD lower plasma phospholipid 15:0 and/or 17:0 concentrations or their main contributor, dairy intake, among GAD65Ab-negative and -positive individuals. Interactions between tertiles of OCFA and GAD65Ab status were estimated by proportion attributable to interaction (AP). RESULTS: Low concentrations of OCFA, particularly 17:0, were associated with a higher incidence of adult-onset diabetes in both GAD65Ab-negative (HR 1.55 [95% CI 1.48, 1.64]) and GAD65Ab-positive (HR 1.69 [95% CI 1.34, 2.13]) individuals. The combination of low 17:0 and high GAD65Ab positivity vs high 17:0 and GAD65Ab negativity conferred an HR of 7.51 (95% CI 4.83, 11.69), with evidence of additive interaction (AP 0.25 [95% CI 0.05, 0.45]). Low dairy intake was not associated with diabetes incidence in either GAD65Ab-negative (HR 0.98 [95% CI 0.94, 1.02]) or GAD65Ab-positive individuals (HR 0.97 [95% CI 0.79, 1.18]). CONCLUSIONS/INTERPRETATION: Low plasma phospholipid 17:0 concentrations may promote the progression from GAD65Ab positivity to adult-onset diabetes. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00125-023-05948-x) contains peer-reviewed but unedited supplementary material.
format Online
Article
Text
id pubmed-10317878
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-103178782023-07-05 Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case–cohort study Lampousi, Anna-Maria Carlsson, Sofia Löfvenborg, Josefin E. Cabrera-Castro, Natalia Chirlaque, María-Dolores Fagherazzi, Guy Franks, Paul W. Hampe, Christiane S. Jakszyn, Paula Koulman, Albert Kyrø, Cecilie Moreno-Iribas, Conchi Nilsson, Peter M. Panico, Salvatore Papier, Keren van der Schouw, Yvonne T. Schulze, Matthias B. Weiderpass, Elisabete Zamora-Ros, Raul Forouhi, Nita G. Sharp, Stephen J. Rolandsson, Olov Wareham, Nicholas J. Diabetologia Article AIMS/HYPOTHESIS: Islet autoimmunity may progress to adult-onset diabetes. We investigated whether circulating odd-chain fatty acids (OCFA) 15:0 and 17:0, which are inversely associated with type 2 diabetes, interact with autoantibodies against GAD65 (GAD65Ab) on the incidence of adult-onset diabetes. METHODS: We used the European EPIC-InterAct case–cohort study including 11,124 incident adult-onset diabetes cases and a subcohort of 14,866 randomly selected individuals. Adjusted Prentice-weighted Cox regression estimated HRs and 95% CIs of diabetes in relation to 1 SD lower plasma phospholipid 15:0 and/or 17:0 concentrations or their main contributor, dairy intake, among GAD65Ab-negative and -positive individuals. Interactions between tertiles of OCFA and GAD65Ab status were estimated by proportion attributable to interaction (AP). RESULTS: Low concentrations of OCFA, particularly 17:0, were associated with a higher incidence of adult-onset diabetes in both GAD65Ab-negative (HR 1.55 [95% CI 1.48, 1.64]) and GAD65Ab-positive (HR 1.69 [95% CI 1.34, 2.13]) individuals. The combination of low 17:0 and high GAD65Ab positivity vs high 17:0 and GAD65Ab negativity conferred an HR of 7.51 (95% CI 4.83, 11.69), with evidence of additive interaction (AP 0.25 [95% CI 0.05, 0.45]). Low dairy intake was not associated with diabetes incidence in either GAD65Ab-negative (HR 0.98 [95% CI 0.94, 1.02]) or GAD65Ab-positive individuals (HR 0.97 [95% CI 0.79, 1.18]). CONCLUSIONS/INTERPRETATION: Low plasma phospholipid 17:0 concentrations may promote the progression from GAD65Ab positivity to adult-onset diabetes. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00125-023-05948-x) contains peer-reviewed but unedited supplementary material. Springer Berlin Heidelberg 2023-06-10 2023 /pmc/articles/PMC10317878/ /pubmed/37301794 http://dx.doi.org/10.1007/s00125-023-05948-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Lampousi, Anna-Maria
Carlsson, Sofia
Löfvenborg, Josefin E.
Cabrera-Castro, Natalia
Chirlaque, María-Dolores
Fagherazzi, Guy
Franks, Paul W.
Hampe, Christiane S.
Jakszyn, Paula
Koulman, Albert
Kyrø, Cecilie
Moreno-Iribas, Conchi
Nilsson, Peter M.
Panico, Salvatore
Papier, Keren
van der Schouw, Yvonne T.
Schulze, Matthias B.
Weiderpass, Elisabete
Zamora-Ros, Raul
Forouhi, Nita G.
Sharp, Stephen J.
Rolandsson, Olov
Wareham, Nicholas J.
Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case–cohort study
title Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case–cohort study
title_full Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case–cohort study
title_fullStr Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case–cohort study
title_full_unstemmed Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case–cohort study
title_short Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case–cohort study
title_sort interaction between plasma phospholipid odd-chain fatty acids and gad65 autoantibodies on the incidence of adult-onset diabetes: the epic-interact case–cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317878/
https://www.ncbi.nlm.nih.gov/pubmed/37301794
http://dx.doi.org/10.1007/s00125-023-05948-x
work_keys_str_mv AT lampousiannamaria interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT carlssonsofia interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT lofvenborgjosefine interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT cabreracastronatalia interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT chirlaquemariadolores interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT fagherazziguy interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT frankspaulw interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT hampechristianes interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT jakszynpaula interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT koulmanalbert interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT kyrøcecilie interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT morenoiribasconchi interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT nilssonpeterm interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT panicosalvatore interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT papierkeren interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT vanderschouwyvonnet interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT schulzematthiasb interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT weiderpasselisabete interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT zamorarosraul interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT forouhinitag interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT sharpstephenj interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT rolandssonolov interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy
AT warehamnicholasj interactionbetweenplasmaphospholipidoddchainfattyacidsandgad65autoantibodiesontheincidenceofadultonsetdiabetestheepicinteractcasecohortstudy